Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - June 2023

Click here to read the articles and download the PDF

Innovation in Heart Disease: A Deep Dive

While generics and adherence challenges are keeping drugmakers up at night, breakthroughs in the pipeline coupled with innovative uses of artificial intelligence and machine learning techniques are bringing optimism to the cardiovascular disease space.

Channel Fragmentation and Diversifying Product Archetypes

New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.

New Trends in Sales Force Organization

The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.

Medicare Still Won’t Pay for Alzheimer’s Drugs Without Confirmatory Data

June 06, 2023

Indicates that reimbursement for new slate of Alzheimer’s treatments will occur only with the completion of studies to support full approval.

KBI Biopharma, Selexis SA Merge as One Organization

June 05, 2023

Decision is anticipated to boost operational efficiencies for the CDMO.

Operational Trends Surrounding the Pharma Sales Process

June 05, 2023

The publication's June installment features a plethora of coverage, ranging from the learning curve in digital adoption to an overview of the CVD market.

New Insights, Fresh Voices

June 05, 2023

As the brand looks to increase its coverage, Pharma Commerce welcomes a pair of editorial contributors to the team.

The Lowdown on Logistics

June 05, 2023

A trip to Eastern France for LogiPharma Europe 2023.

WuXi Biologics Expands Manufacturing Capacity in Germany

June 02, 2023

Company is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.

IRA Journey Update

June 02, 2023

The latest on its implementation—and the implications for biopharma.

Addressing Rx Affordability

June 02, 2023

The Medicare Part D cap in 2025 won’t solve patients’ need for financial assistance.

Channel Fragmentation and Diversifying Product Archetypes

June 02, 2023

New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.

Innovation in Heart Disease: A Deep Dive

June 01, 2023